A. Frydén

发表

Hepatocyte Growth Factor may Act as an Early Therapeutic Predictor in Pneumonia

I. Nilsson, L. Brudin, P. Forsberg, 2002, Scandinavian journal of infectious diseases.

Virologic investigation of a case of suspected haemorrhagic fever.

P. Jahrling, C. Peters, A. Frydén, 1994, Research in virology.

Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study.

A. Bengtsson, A. Frydén, R. Schvarcz, 1990, BMJ.

The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients.

A. Frydén, L. Franzén, U. Mathiesen, 1999, Scandinavian journal of gastroenterology.

Acute "idiopathic" peripheral facial palsy: clinical, serological, and cerebrospinal fluid findings and effects of corticosteroids.

L. Odkvist, P. Forsberg, A. Frydén, 1993, American journal of otolaryngology.

Demonstration of cerebrospinal fluid lymphocytes sensitized against virus antigens in mumps meningitis

A. Frydén, H. Link, E. Möller, 1978, Acta Neurologica Scandinavica.

Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

E. Bjornsson, E. Skovlund, A. Frydén, 2007, Hepatology.

Two‐year biochemical, virological, and histological follow‐up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa‐2b treatment

O. Weiland, G. Norkrans, A. Sönnerborg, 1995, Hepatology.

Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis.

O. Weiland, G. Norkrans, A. Frydén, 2008, Liver.

A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies.

O. Weiland, G. Norkrans, A. Frydén, 1989, Scandinavian journal of infectious diseases.

Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: Epidemiological applications

O. Weiland, A. Widell, G. Norkrans, 1994, Journal of medical virology.

Serum bile acids in Gilbert's syndrome before and after reduced caloric intake.

A. Frydén, G. Briheim, P. Tobiasson, 1982, Scandinavian journal of gastroenterology.

Sulfur amino acid metabolism in hepatobiliary disorders.

O. Weiland, A. Frydén, M. Schwartz, 1992, Scandinavian journal of gastroenterology.

A clinical and epidemiological study of "ornithosis" caused by Chlamydia psittaci and Chlamydia pneumoniae (strain TWAR).

A. Frydén, K. Persson, E. Kihlström, 1989, Scandinavian journal of infectious diseases.

Yersinia enterocolitica septicemia: clinical and microbiological aspects.

O. Weiland, A. Frydén, K. Persson, 1986, Scandinavian journal of infectious diseases.

Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

A. Frydén, K. Alestig, K. Lövgren, 1984, Lancet.

Long-term findings in patients with facial palsy and antibodies against Borrelia burgdorferi.

L. Odkvist, P. Forsberg, A. Frydén, 1994, Scandinavian journal of infectious diseases.

Acute peripheral facial palsy: CSF findings and etiology

J. Ernerudh, P. Forsberg, A. Frydén, 1991, Acta neurologica Scandinavica.

Production of Specific Antibodies by Cerebrospinal Fluid Lymphocytes in Patients with Herpes Zoster, Mumps Meningitis and Herpes Simplex Virus Encephalitis

P. Forsberg, A. Frydén, S. Kam‐Hansen, 1986, Scandinavian journal of immunology.

High Serum Hepatocyte Growth Factor Levels in the Acute Stage of Community-acquired Infectious Diseases

I. Nilsson, L. Brudin, P. Forsberg, 2002, Scandinavian journal of infectious diseases.

Long-term follow-up of sustained responders to interferon therapy

O. Weiland, G. Norkrans, A. Frydén, 1998 .

Tuberculous Meningitis: Immune Reactions within the Central Nervous System

A. Frydén, H. Link, S. Eriksson, 1981, Scandinavian journal of immunology.

Reduced in Vitro Response of CSF Lymphocytes to Mitogen Stimulation in Multiple Sclerosis

A. Frydén, S. Kam‐Hansen, H. Link, 1979, Scandinavian journal of immunology.

B and T lymphocytes in cerebrospinal fluid and blood in multiple sclerosis, optic neuritis and mumps meningitis

A. Frydén, S. Kam‐Hansen, H. Link, 1978, Acta neurologica Scandinavica.

B and T Lymphocytes in Blood and Cerebrospinal Fluid in Acute Aseptic Meningitis

A. Frydén, 1977, Scandinavian journal of immunology.

HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile

O. Weiland, A. Widell, G. Norkrans, 1995, Infection.

Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive.

A. Widell, A. Frydén, U. Mathiesen, 1996, Scandinavian journal of infectious diseases.

Second‐Generation Hepatitis C Elisa Antibody Tests Confirmed by the Four‐Antigen Recombinant Immunoblot Assay Correlate Well with Hepatitis C Viremia and Chronic Liver Disease in Swedish Blood Donors

O. Weiland, A. Widell, G. Norkrans, 1993, Vox sanguinis.

Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.

A. Widell, R. Norlin, A. Frydén, 1992, Scandinavian journal of gastroenterology.

Viral antibodies in oligoclonal and polyclonal IgG synthesized within the central nervous system over the course of mumps meningitis

A. Frydén, H. Link, M. A. Laurenzi, 1981, Journal of Neuroimmunology.

Legionnaires' disease in leukaemic reticuloendotheliosis.

A. Frydén, C. Malm, R. Maller, 2009, Scandinavian journal of haematology.

Lymphocyte subsets and β2‐microglobulin expression in chronic hepatitis C/non‐A, non‐B. Effects of interferon‐alpha treatment

D. Fuchs, O. Weiland, G. Norkrans, 1992, Clinical and experimental immunology.

Viral IgM and IgG antibody synthesis within the central nervous system in mumps meningitis

P. Forsberg, A. Frydén, H. Link, 1986, Acta neurologica Scandinavica.

MITOGEN STIMULATION AND DISTRIBUTION OF T‐ AND B‐LYMPHOCYTES DURING NATURAL RUBELLA INFECTION

A. Frydén, R. Maller, L. Sörén, 1978, Acta pathologica et microbiologica Scandinavica. Section C, Immunology.

Mitogen stimulation of cerebrospinal fluid lymphocytes in aseptic meningitis

A. Frydén, H. Link, Aril Frydén, 1978, Acta neurologica Scandinavica.

Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C.

O. Weiland, G. Norkrans, A. Sönnerborg, 1998, Scandinavian journal of infectious diseases.

Benign meningococcemia in childhood. A report of five cases with clinical and diagnostic remarks.

A. Frydén, O. Eeg‐Olofsson, P. Olcén, 1978, Scandinavian journal of infectious diseases.

Normal leukocyte counts in Staphylococcus aureus septicaemia.

A. Frydén, B. al Awar, 1990, Scandinavian Journal of Infectious Diseases.

Successful treatment of hepatic coma probably caused by acute infectious hepatitis with balanced solution of amino acids.

O. Weiland, A. Frydén, J. Mårtensson, 1982, Scandinavian journal of infectious diseases.

Active and total T cells in blood and cerebrospinal fluid during the course of aseptic meningitis

A. Frydén, S. Kam‐Hansen, H. Link, 1980, Acta neurologica Scandinavica.

Cerebrospinal fluid and serum immunoglobulins and antibody titers in mumps meningitis and aseptic meningitis of other etiology

E. Norrby, A. Frydén, H. Link, 1978, Infection and immunity.

ACYCLOVIR VERSUS VIDARABINE IN HERPES SIMPLEX ENCEPHALITIS Randomised Multicentre Study in Consecutive Swedish Patients

A. Frydén, K. Alestig, M. Forsgren, 1984, The Lancet.

Peripheral blood lymphocyte subsets in patients with chronic hepatitis C--effects of interferon treatment.

O. Weiland, G. Norkrans, A. Frydén, 2008, Liver.

Humoral immune response to individual Yersinia enterocolitica antigens in patients with and without reactive arthritis.

A. Frydén, E. Kihlström, A. Grönberg, 1989, Clinical and experimental immunology.

Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine.

A. Frydén, M. Sällberg, K. Cardell, 2008, The Journal of infectious diseases.

Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine.

A. Frydén, M. Sällberg, T. Björnsdóttir, 2008, Vaccine.

Intradermal hepatitis B vaccination in health care workers. Response rate and experiences from vaccination in clinical practise.

A. Frydén, B. Normann, K. Cardell, 1999, Scandinavian journal of infectious diseases.

High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon‐α2b for 60 weeks

O. Weiland, G. Norkrans, A. Sönnerborg, 1994, Hepatology.

Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

Aril Frydén, Anders Sönnerborg, Gunnar Norkrans, 1998, The Lancet.

Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course.

O. Weiland, G. Norkrans, A. Frydén, 2008, Liver.

Septicemia and meningitis caused by Fusobacterium aquatile.

A. Frydén, R. Maller, S. Ånséhn, 1978, Scandinavian journal of infectious diseases.

Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon.

O. Weiland, G. Norkrans, A. Frydén, 1999, Journal of hepatology.

Serum hepatitis C virus RNA levels in chronic hepatitis C--importance for outcome of interferon alfa-2b treatment.

J. Lundeberg, O. Weiland, G. Norkrans, 1994, Scandinavian journal of infectious diseases.

Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B/C hepatitis: long-term outcome and effect of increased interferon doses in non-responders.

O. Weiland, G. Norkrans, A. Frydén, 1991, Scandinavian journal of infectious diseases.

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group.

O. Weiland, G. Norkrans, A. Sönnerborg, 1998, Lancet.

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study.

H. Thomas, O. Weiland, G. Norkrans, 1996, Journal of hepatology.

Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis C.

O. Weiland, G. Norkrans, A. Frydén, 1999, Scandinavian journal of infectious diseases.

Interaction of Staphylococcus epidermidis from infected hip prostheses with neutrophil granulocytes.

A. Frydén, P. Lindgren, O. Stendahl, 2001, Scandinavian journal of infectious diseases.

Viral haemorrhagic fever in Sweden: experiences from management of a case.

P. Jahrling, A. Frydén, B. Niklasson, 1991, Scandinavian journal of infectious diseases.

Liver guide for monitoring of chronic hepatitis C

Kristina Hedin, Ankica Babic, Aril Frydén, 2000, AMIA.

PRODUCTION OF SPECIFIC ANTIBODIES BY CSF LYMPHOCYTES IN PATIENTS WITH HERPES ZOSTER

P. Forsberg, A. Frydén, S. Kam‐Hansen, 1984, The Lancet.

GBV‐C/HGV infection in hepatitis C virus‐infected deferred Swedish blood donors

O. Weiland, A. Widell, G. Norkrans, 1998, Journal of medical virology.

Long‐term follow‐up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure

O. Weiland, G. Norkrans, T. Pietschmann, 2015, Alimentary pharmacology & therapeutics.

No association between oligoclonal immunoglobulins in cerebrospinal fluid and HLA antigens in acute aseptic meningitis

A. Frydén, H. Link, E. Möller, 1979, Neurology.

Serum bile acids after test meals and oral load of chenodeoxycholic acid.

A. Frydén, P. Tobiasson, C. Tagesson, 1981, Scandinavian journal of gastroenterology.

Serum bile acid determination after different doses of orally ingested chenodeoxycholic acid. Evaluation of a simplified enzymatic method.

A. Frydén, B. Kågedal, U. Foberg, 1985, Scandinavian journal of gastroenterology.

Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b.

D. Fuchs, O. Weiland, G. Norkrans, 1992, The European journal of medicine.

Platelets enhance neutrophil locomotion: evidence for a role of P-selectin.

A. Frydén, M. Grenegård, T. Bengtsson, 1999, Scandinavian journal of clinical and laboratory investigation.

[Clostridium difficile enteritis complicated by symphysitis. Good effect of fecal streptococci].

H. Tropp, A. Frydén, L. Ohman, 1993, Lakartidningen.

High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation.

M. Ekstedt, A. Frydén, H. Enocsson, 2012, Human immunology.

E. Björnsson, A. Frydén, E. Kalaitzakis, 2009, Scandinavian journal of gastroenterology.

DESIGN OF THERAPEUTIC STUDIES IN HERPES SIMPLEX ENCEPHALITIS

M. Hirsch, S. Soong, A. Frydén, 1985, The Lancet.

Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.

A. Widell, A. Frydén, L. Franzén, 1993, Scandinavian journal of gastroenterology.

Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases.

G Bodemar, A. Frydén, L. Franzén, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Nosocomial hepatitis C in a thoracic surgery unit; retrospective findings generating a prospective study.

A. Widell, A. Frydén, A. Månsson, 2008, The Journal of hospital infection.

Intestinal symptoms and serological response in patients with complicated and uncomplicated Yersinia enterocolitica infections.

A. Bengtsson, A. Frydén, R. Schvarcz, 1992, Scandinavian journal of infectious diseases.

Immunoglobulin abnormalities in the cerebrospinal fluid during bacterial meningitis

P. Forsberg, A. Frydén, H. Link, 1986, Journal of Neuroimmunology.

Take Care: Guidelines for Patients with Chronic Hepatitis C

Kristina Hedin, Ankica Babic, Aril Frydén, 1999, MIE.

Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience.

O. Weiland, G. Norkrans, A. Frydén, 1990, Journal of hepatology.

Comparison of three bile acid provocation tests. Intravenous cholecystokinin, a standard test meal, and an oral bile acid load in healthy subjects.

A. Frydén, B. Kågedal, U. Foberg, 1987, Scandinavian journal of gastroenterology.

Evaluation of an oral bile acid loading test for assessment of liver function in chronic hepatitis. A comparison with fasting serum bile acids and i.v. galactose elimination test.

O. Weiland, A. Frydén, B. Kågedal, 2008, Liver.

Studies of Immune Reactions in Multiple Sclerosis by Active T-Rosette Test, Immunofixation, and Myelinotoxicity of Lymphocytes in the Rabbit Eye

K. Kristensson, A. Frydén, S. Kam‐Hansen, 1980 .

Predominance of Oligoclonal IgG Type λ in CSF in Aseptic Meningitis-Reply

A. Frydén, H. Link, 1979 .

Characterization of antibody activity in oligoclonal immunoglobulin G synthesized within the central nervous system in a patient with tuberculous meningitis

A. Frydén, H. Link, J. Kinnman, 1981, Journal of clinical microbiology.

Two‐year biochemical, virological, and histological follow‐up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa‐2b treatment

O. Weiland, G. Norkrans, A. Sönnerborg, 1995, Hepatology.

Haemophilus parainfluenzae infection of the central nervous system. A report on two infants.

A. Frydén, R. Maller, S. Ånséhn, 1977, Scandinavian journal of infectious diseases.

Predominance of oligoclonal IgG type lambda in CSF in aseptic meningitis.

A. Frydén, H. Link, 1979, Archives of neurology.

Mumps with laboratory signs of subclinical pancreatitis may cause a disturbed beta-cell function.

A. Frydén, M. Marshall, Johnny Ludvigsson, 1988, Diabetes research.

Synthesis of the complement factors C3 and C4 within the central nervous system over the course of aseptic meningitis

P. Forsberg, A. Frydén, H. Link, 1992, Acta neurologica Scandinavica.

Synthesis of the complement factors C3 and C4 within the central nervous system over the course of aseptic meningitis

P. Forsberg, A. Frydén, H. Link, 1983 .

Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine.

A. Frydén, M. Sällberg, K. Cardell, 2008, The Journal of infectious diseases.